RBC Capital analyst, Adnan Butt, reiterated his Outperform rating on shares of Curis (NASDAQ: CRIS) reiterating that the company is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE